IFNG and acute myeloid leukemia: In addition, because interferon (IFN)α enhances IFNγ and IL-12 secretion, which in turn triggers NK cytotoxicity, Lion et al. proposed IFNα post-CR maintenance immunotherapy for AML patients [55].